Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 2.22MStock Based Compensation
VS
Market
Sector
Industry
History
$ 8.34Close
$ 6.41 - $ 16.8 52-Week Range
Ticker Information
Ticker
GYRECompany Name
GYRE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQGYRE THERAPEUTICS INC - Stock Based Compensation Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
GYRE - SB Comp. Historical data
| Date | Stock Based Compensation |
|---|---|
| 6/30/2025 | $ 2.22M |
| 3/31/2025 | $ 1.33M |
| 12/31/2024 | $ 831K |
| 9/30/2024 | $ 7.15M |
| 6/30/2024 | $ 7.01M |
| 3/31/2024 | $ 7.08M |
| 12/31/2023 | $ 7.28M |
| 9/30/2023 | $ 654K |
| 6/30/2023 | $ 780K |
| 3/31/2023 | $ 1.04M |
Key Performance Insights, Last 5 Years
- GYRE THERAPEUTICS INC's latest trailing twelve months (TTM) SB Comp. stands at $ 3.38M.
- Over the past 5 years, GYRE THERAPEUTICS INC's average SB Comp. has been $ 3.28M.
- The median SB Comp. for GYRE THERAPEUTICS INC during this period was $ 3.14M
- GYRE THERAPEUTICS INC reached its highest SB Comp. over the past 5 years at $ 7.28M.
- The lowest SB Comp. recorded by GYRE THERAPEUTICS INC in the same timeframe $ 654K
GYRE THERAPEUTICS INC's SB Comp. vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp. Benchmarks
Similar metrics to SB Comp.:
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
Definition of Stock Based Compensation
[Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].GYRE - Stock Based Compensation, Last 5 years
$ 654K
Minimum
Sep 30, 2023
$ 7.28M
Maximum
Dec 31, 2023
$ 3.28M
Average
$ 3.14M
Median
SB Comp. Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp. for companies in the Total Stock Market. The average SB Comp. of the companies is $ 12.11M with a standard deviation of $ 14.36M.
The following table provides additional summary stats:
SB Comp. in the Market:
| filtered constituents | 3.52K |
|---|---|
| min | $ -20.28M |
| max | $ 59.14M |
| average | $ 12.11M |
| median | $ 6.31M |
| std | $ 14.36M |